Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam

被引:102
作者
Cramer, JA
Arrigo, C
Van Hammée, G
Bromfield, EB
机构
[1] Yale Univ, Sch Med, Yale VA Med Ctr, Dept Psychiat, West Haven, CT 06516 USA
[2] Yale Univ, Sch Med, Yale VA Med Ctr, Dept Neurol, West Haven, CT 06516 USA
[3] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[4] UCB Bioprod SA, Pharma Sector Res & Dev, Clin Epidemiol & Outcomes Res Unit, Braine Lalleud, Belgium
关键词
levetiracetam; quality of life; QOLIE-31; QOLIE-10; clinical trial;
D O I
10.1016/S0920-1211(00)00127-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: to determine whether the QOLIE-10, an abbreviated quality of life questionnaire, provides results similar to the more detailed QOLIE-31 instrument when the ten items are derived from the QOLIE-31. Methods: the QOLIE-31 was completed by 246 patients participating in UCB protocol N132 at baseline and after 18 weeks of treatment with levetiracetam (LEV 1000 or 3000 mg) or placebo added to standard therapy. QOLIE-10 components and total scores were calculated from the QOLIE-31 data. Results: baseline QOLIE-10 components and total score correlated highly with corresponding QOLIE-31 scores, both at baseline and follow-up (range 0.70-0.95). Changes from baseline to follow-up were significantly different (ANCOVA) among treatment groups for both the QOLIE-10 and QOLIE-31 for the total score (P = 0.02, P = 0.009, respectively), seizure worry (P = 0.005, P = 0.0003) and cognitive functioning (P = 0.01, P = 0.01). One subscale (overall QOL) showed significant change with the QOLIE-31 (P = 0.04), but not with the QOLIE-10 (P = 0.07). Differences in QOLIE-10 scores were found between responders (greater than or equal to 50% partial onset seizure reduction) and non-responders for the total score (P = 0.0001) and two components (overall QOL P = 0.002, social function P = 0.0003). In the QOLIE-31, the total score and six subscale scores tall except medication effects) were significantly different. Both instruments were able to detect change over time. Responsiveness assessed by effect sizes (- 0.1 for non-responders, 0.4 for responders, 0.8 for seizure-free patients) and the Guyatt statistic (- 0.1, 0.6 and 1.0, respectively) was similar for both instruments. Conclusions: although the QOLIE-10 was designed as a screening tool, it can be scored and used in research. The total score did discern differences among treatments in a clinical trial. Nonetheless, questionnaires with multiple, multi-item subscales provide more detailed information than abbreviated forms. The QOLIE-31 is preferred where time and resources are available. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 18 条
[1]   THE INITIAL DEVELOPMENT OF A HEALTH-RELATED QUALITY-OF-LIFE MODEL AS AN OUTCOME MEASURE IN EPILEPSY [J].
BAKER, GA ;
SMITH, DF ;
DEWEY, M ;
JACOBY, A ;
CHADWICK, DW .
EPILEPSY RESEARCH, 1993, 16 (01) :65-81
[2]  
Cohen J., 1969, STAT POWER ANAL BEHA
[3]   A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10 [J].
Cramer, JA ;
Perrine, K ;
Devinsky, O ;
Meador, K .
EPILEPSIA, 1996, 37 (06) :577-582
[4]   Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory [J].
Cramer, JA ;
Perrine, K ;
Devinsky, O ;
Bryant-Comstock, L ;
Meador, T ;
Hermann, B .
EPILEPSIA, 1998, 39 (01) :81-88
[5]  
CRAMER JA, 2000, UNPUB EFFECT LEVETIR
[6]  
Cramer JA, 1996, QUALITY LIFE PHARMAC, P909
[7]   DEVELOPMENT OF THE QUALITY-OF-LIFE IN EPILEPSY INVENTORY [J].
DEVINSKY, O ;
VICKREY, BG ;
CRAMER, J ;
PERRINE, K ;
HERMANN, B ;
MEADOR, K ;
HAYS, RD .
EPILEPSIA, 1995, 36 (11) :1089-1104
[8]   AN OBJECTIVE METHOD FOR THE ASSESSMENT OF PSYCHOLOGICAL AND SOCIAL-PROBLEMS AMONG EPILEPTICS [J].
DODRILL, CB ;
BATZEL, LW ;
QUEISSER, HR ;
TEMKIN, NR .
EPILEPSIA, 1980, 21 (02) :123-135
[9]   MEASURING CHANGE OVER TIME - ASSESSING THE USEFULNESS OF EVALUATIVE INSTRUMENTS [J].
GUYATT, G ;
WALTER, S ;
NORMAN, G .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (02) :171-178
[10]   HOSPITAL QUALITY TRENDS - A SHORT-FORM PATIENT-BASED MEASURE [J].
HAYS, RD ;
LARSON, C ;
NELSON, EC ;
BATALDEN, PB .
MEDICAL CARE, 1991, 29 (07) :661-668